SpyGlass Pharma, Inc. SEC filings SGP

SpyGlass Pharma, Inc. has 92 filings in SEC EDGAR's recent list, going back to Jun 5, 2019. Its latest annual report, Form 10-K, was filed on Mar 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 19, 2026 (other events). The company's fiscal year ends on December 31.

Form Description Filed Period
CERT Filing Feb 5, 2026 —
8-A12B Filing Feb 5, 2026 —
EFFECT Filing Jan 30, 2026 —
CORRESP Letter to the SEC Jan 29, 2026 —
CORRESP Letter to the SEC Jan 29, 2026 —
CORRESP Letter to the SEC Jan 29, 2026 —
UPLOAD Letter from the SEC Jan 27, 2026 —
CORRESP Letter to the SEC Jan 16, 2026 —
UPLOAD Letter from the SEC Jan 13, 2026 —
DRS/A Filing Dec 10, 2025 —
DRSLTR Filing Dec 9, 2025 —
UPLOAD Letter from the SEC Dec 1, 2025 —
DRS Filing Sep 26, 2025 —
D Filing Jun 5, 2025 —
D Filing Jul 11, 2023 —
D Filing Jan 5, 2021 —
D Filing Jun 5, 2019 —

Showing 17 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
SGP (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Irvine, CA
SEC filer status
, Emerging growth company
SEC CIK
1778922
Former names
SpyGlassPharma, Inc. (until Jun 5, 2025); SpyGlass Ophthalmics, Inc. (until Jan 5, 2021)

Other Surgical & Medical Instruments & Apparatus companies

All 151 Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.